The effect of cannabis laws on opioid use

被引:19
作者
Flexon, Jamie L. [1 ]
Stolzenberg, Lisa [1 ]
D'Alessio, Stewart J. [1 ]
机构
[1] Florida Int Univ, Green Sch Int & Publ Affairs, Dept Criminol & Criminal Justice, Modesto A Maidique Campus,SW 8th St 11200, Miami, FL 33199 USA
关键词
Medical Marijuana Laws; Opioids; Chronic pain management; Cannabis; MEDICAL MARIJUANA LAWS; CHRONIC PAIN; UNITED-STATES; SUBSTITUTION; LEGALIZATION; PREVALENCE; SUBSTANCES; ADOLESCENT; ATTITUDES; TOXICITY;
D O I
10.1016/j.drugpo.2019.09.013
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Many Americans rely on opioids at varying dosages to help ameliorate their suffering. However, empirical evidence is mounting that opioids are ineffective at controlling non-cancer related chronic pain, and many argue the strategies meant to relieve patient suffering are contributing to the growing opioid epidemic. Concurrently, several states now allow the use of medical cannabis to treat a variety of medical conditions, including chronic pain. Needing more exploration is the impact of cannabis laws on general opioid reliance and whether chronic pain sufferers are opting to use cannabis medicinally instead of opioids. Methods: This study investigates the effect of Medical Marijuana Laws (MML)s on opioid use and misuse controlling for a number of relevant factors using data from several years of the National Survey on Drug Use and Health and multivariate logistic regression and longitudinal analysis strategies. Results: Results provide evidence that MMLs may be effective at reducing opioid reliance as survey respondents living in states with medical cannabis legislation are much less apt to report using opioid analgesics than people living in states without such laws, net other factors. Results further indicate that the presence of medicinal cannabis legislation appears to have no influence over opioid misuse. Conclusion: MMLs may ultimately serve to attenuate the consequences of opioid overreliance.
引用
收藏
页码:152 / 159
页数:8
相关论文
共 57 条
  • [1] Cannabinoid-Opioid Interaction in Chronic Pain
    Abrams, D. I.
    Couey, P.
    Shade, S. B.
    Kelly, M. E.
    Benowitz, N. L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (06) : 844 - 851
  • [2] [Anonymous], LAT PRESCR TRENDS CO
  • [3] [Anonymous], 2016, 2015 NATL SURVEY DRU
  • [4] [Anonymous], 2014, RES 2013 NAT SURV DR
  • [5] [Anonymous], HEALTH
  • [6] [Anonymous], 2012, PAIN PHYS
  • [7] [Anonymous], HHS PUBL SMA
  • [8] [Anonymous], LIMDEP VERS 11
  • [9] [Anonymous], 2019, OV DEATH RAT
  • [10] Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010
    Bachhuber, Marcus A.
    Saloner, Brendan
    Cunningham, Chinazo O.
    Barry, Colleen L.
    [J]. JAMA INTERNAL MEDICINE, 2014, 174 (10) : 1668 - 1673